The FDA Law Blog

JANUARY 4, 2024

This unique forum, designed for in-house counsel and executives, as well as private practice attorneys working for the OTC drug industry will provide invaluable insights on FDA’s most recent directives and compliance standards governing OTC drug production, marketing and distribution. The discount code is: S10-826-826L24.S.

FDA 52

FDA 52

pharmaphorum

NOVEMBER 23, 2022

Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and discuss not only its consulting operations, but the company’s Smart Reviewer, and their own assessment of the industry event itself.

Dosage 98

Dosage Documentation Hospitals Vaccines 98

STAT

AUGUST 17, 2023

In any event, there is work to be done, so as always, we have assembled a few items of interest for you. appeals court panel restricted access to the abortion pill mifepristone but did not remove it from the market entirely, partially upholding a lower court decision , STAT reports. … A U.S. … A U.S.

91

91

ISPE

AUGUST 3, 2023

In this role, she is responsible for a variety of duties, including Project Coordination, Meeting & Event Logistics, Marketing, Social Media coordination & communication. Truly multilayered, Tracy is also the co-owner of The Girls and The Grapes, where she brings exceptional wine experiences and education to market.

Communication 98

Communication Patient Care 98

pharmaphorum

OCTOBER 20, 2022

Meanwhile, the workshop ‘Reimagining the life sciences marketing and sales model in a digital first world’ will be moderated by Eversana’s chief digital officer Scott Snyder, and Healthware Group’s global head of science Elisabetta Ravot will be running a session on ‘Research applications: robotics and multi-omics’.

118

118

Pharma Marketing Network

FEBRUARY 16, 2021

These companies had to make a quick turnaround and transfer all of their in-person information into digital materials that could be easily accessible online for their attendees. Now that we are in 2021 and virtual events are here to stay, here are some tips on how to continue increasing your online engagement when hosting virtual events.

Communication 98

Communication 98

Pharma Marketing Network

JUNE 7, 2022

Upcoming Informa Connect Events: Hub and Specialty Pharmacy Models East – June 28-30, 2022. PAP – Patient Assistance & Access Programs – June 28-30, 2022. Copay, Reimbursement, and Access Congress – October 12-14, 2022. Transparency, Aggregate Spend & HCP Engagement – August 9-11, 2022.

Specialty Pharmacies 40

Specialty Pharmacies 40

PQA

MARCH 8, 2024

We are in the early stages of planning an event, PQA Convenes: Quality Medication Use in Rare Disease, which will bring our members and the rare disease community together to explore quality in medication use. This one-day event will take place on Thursday, November 7, 2024, in Arlington, Va., Learn more below. Register today!

Community Pharmacies 52

Community Pharmacies Specialty Pharmacies Independent Pharmacies Documentation 52

pharmaphorum

NOVEMBER 25, 2021

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. The changing events model. Before COVID, pharma events were mainly face-to-face.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

AUGUST 17, 2022

The incidence of adverse events, including those of grade 3 or higher, during treatment was higher in the lutetium ( 177 Lu) vipivotide tetraxetan plus SOC group than in the SOC only group11. The most common treatment-emergent adverse events in those receiving lutetium ( 177 Lu) vipivotide tetraxetan plus SOC (all grades) were fatigue (43.1

Chemotherapy 117

Chemotherapy Compounding Labelling 117

Pharma Marketing Network

DECEMBER 8, 2022

Upcoming Informa Connect Events: Speaker Programs Summit – February 27-March 1, 2023. PAP – Patient Assistance & Access Programs – March 20-22, 2023. The post Informa Connect 2023 Events appeared first on Pharma Marketing Network. Pharma Forum – March 19-22, 2023.

Specialty Pharmacies 40

Specialty Pharmacies 40

European Pharmaceutical Review

SEPTEMBER 5, 2023

Wegovy is accessible in specialist NHS weight management services for patients who meet the specified National Institute for Care and Excellence (NICE) criteria. Prior to this new market launch, Wegovy was only available in Norway, Denmark, Germany and the US.

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies Labelling 93

Pharma Marketing Network

JULY 3, 2021

Join the Society for Health Care Strategy and Market Development (SHSMD) at their annual conference, SHSMD Connections 2021 this autumn. Tracks at this year’s event include: marketing, cross-disciplinary & innovation, community & public relations, strategic planning & business development, digital engagement, and leadership.

52

52

Pharmaceutical Technology

SEPTEMBER 22, 2022

Your healthcare practitioner can access the sequencing results, and artificial intelligence (AI) and quantum computing will analyse these records and support the practitioner in making future clinical decisions. It could be that you are lucky, and there is already a cancer vaccine on the market that you will get priority for.

Vaccines 137

Vaccines Hospitals 137

Pharma Marketing Network

JANUARY 11, 2022

Pharma USA 2022 is North America’s leading commercial pharma event. Join 1000+ industry executives from Commercial, Marketing, Medical Affairs, Patient Engagement, Market Access, and Real-World Evidence to form new collaborations and gain new business-critical insights. For pharma, that moment is now.

52

52

PharmaShots

FEBRUARY 28, 2023

Vascepa’s marketing authorization has been granted in Great Britain in April 2021 & the therapy is currently approved and sold in the EU in Sweden, Denmark, Finland, Austria & the UK Ref: Amarin | Image: Amarin Related Post:- Amarin Reports (REDUCE-IT) Trial Results of Vascepa/Vazkepa (icosapent ethyl) for Cardiovascular Diseases

40

40

pharmaphorum

NOVEMBER 27, 2022

Its secondary endpoints were time to pain progression and time to first symptomatic skeletal event. CEO of Bayer UK & Ireland, Antonio Payano, said: “We are delighted that men with prostate cancer in England will have early access to another innovative treatment option.

Hospitals 98

Hospitals FDA 98

Hospital Pharmacy Europe

OCTOBER 20, 2023

While current DLBCL treatments such as CAR T therapies are provided in specialist centres across England, glofitamab can be offered at more cancer treatment sites across the country, improving timely access. The most common adverse event was cytokine release syndrome (CRS) (63%).

Chemotherapy 52

Chemotherapy Immunization Hospitals 52

pharmaphorum

JUNE 8, 2022

The move marks the largest expansion of FH to date and allows clients to benefit from integrated offerings spanning policy, access, value, and evidence. The addition of Avalere’s more than 200 advisors deepens FH’s US market presence and diversifies its customer base. We are excited to welcome Avalere to FH.” .

Communication 52

Communication 52

Pharmaceutical Technology

APRIL 28, 2023

Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn. The significant sales growth of Ozempic reinforces its continued dominance in the type 2 diabetes market.

Dosage 52

Dosage Compounding Labelling FDA 52

The FDA Law Blog

SEPTEMBER 10, 2023

In contrast, as the guidance explains, a non-interventional study (also referred to as an observational study) is a type of study in which patients received the marketed drug of interest during routine medical practice and are not assigned to an intervention according to a protocol.

FDA 108

FDA Documentation Vaccines 108

ISPE

MAY 22, 2023

Regulatory speakers were Lisa Hedman, Group Lead for the Division of Supply and Access to Medicines of the World Health Organization (WHO); and Joyce Cirunay, Director IV of the Center for Drug Regulation and Research at the Philippines FDA. The webinar was moderated by Vivien Santillan, Regional Director, Asia, Novatek International.

Communication 98

Communication FDA 98

pharmaphorum

AUGUST 24, 2020

The Oncology Center of Excellence’s Project Patient Voice , combined with the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events ( PRO-CTCAE ), hope to change that. . Project Patient Voice .

Labelling 128

Labelling Communication FDA 128

pharmaphorum

JULY 22, 2022

An event that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point. In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Event Hashtag: #PharmaCleanroom.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

ISPE

JUNE 7, 2023

He provides a strong level of experience related to Digital Branding, Marketing & Strategic Communication. He joined the PQE group in 2017 and currently serves as the Vice President of Strategy, Marketing, Communications & Equity Partner. A big highlight was serving as a moderator at an event when I first started out with ISPE.

Communication 94

Communication 94

PQA

APRIL 11, 2023

is one of most affordable and accessible national meetings: Registration is just $499 and includes two breakfasts, three lunches and two receptions. We have more than 50 speakers across 20 sessions and events that will share insights on how to succeed in today's competitive and rapidly changing health care market.

Packaging 52

Packaging 52

pharmaphorum

JANUARY 6, 2023

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. But against the backdrop of current global events, a conservative approach makes sense. Ensuring patient access. Retaining business begins with patient access. Industry frustrations.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JANUARY 17, 2022

As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. The 2022 event will be more significant than ever before due to the transition period after Brexit coming to an end.

Packaging 52

Packaging Vaccines 52

PQA

FEBRUARY 29, 2024

Like all patients, individuals with rare disease want medications that are accessible, safe, effective and help them achieve the best outcomes possible. This one-day event will take place on Thursday, November 7, 2024, in Arlington, Va., We look forward to sharing more about this event in the coming months.

Specialty Pharmacies 45

Specialty Pharmacies Communication Patient Care 45

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Go-to-market strategies. The challenge of providing adequate access to the peripheral EU markets is quite evident. Efforts have been made to change this.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

Pharma Marketing Network

MAY 11, 2023

Prior to the pandemic, healthcare conferences were typically large in-person events, attracting thousands of attendees from around the world. One of the most significant changes in healthcare conferences since 2020 has been the shift to virtual events.

Patient Care 52

Patient Care 52

ISPE

MAY 16, 2023

For those of you following this space I’m sure you can appreciate the roller coaster of events across crypto, blockchain, and pharma over that time. According to a report by Grand View Research, the global blockchain technology market in healthcare is expected to grow at a compound annual growth rate (CAGR) of 66.1% from 2021 to 2028.

Compounding 98

Compounding 98

Pharmaceutical Technology

FEBRUARY 24, 2023

The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years.

Documentation 64

Documentation 64

Hospital Pharmacy Europe

OCTOBER 12, 2023

Previous studies have found increased risk of gastrointestinal adverse events with use of glucagon-like peptide 1 (GLP-1) agonists in patients with diabetes. Semaglutide, marketed as Wegovy, first became available on the NHS as a weight-loss drug in September, after a limited stock was earmarked to fulfil new NICE guidance.

Medical Records 52

Medical Records Hospitals 52

Pharma Marketing Network

JULY 28, 2021

With precision analytics as an anchor behind data-driven decision-making, new advancements in data quality and access, plus rising cultural acceptance to innovation – we’re finally moving towards digital maturity. Reuters Events’ Pharma Marketing USA 2021 is where the future of the pharma customer experience is pioneered.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

OCTOBER 1, 2022

Diarrhoea, nausea, upper respiratory tract infection and abdominal pain were reported to be the most common adverse events linked to Relyvrio. The Marketing Authorisation Application submitted by the company for the therapy is being reviewed by the European Medicines Agency (EMA) for ALS.

FDA 97

FDA Dosage Labelling 97

ISPE

MARCH 6, 2023

At the same time, many companies are pursuing localized manufacturing to adjust to supply chain challenges and to improve access to medicine. Successfully managing a broad portfolio, expanding global access, and maintaining margins requires greater manufacturing agility while adhering to industry regulations.

Communication 97

Communication FDA Pharmaceutical Companies Pharmaceutical Companies 97